| A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts S Huet, B Tesson, JP Jais, AL Feldman, L Magnano, E Thomas, ... The lancet oncology 19 (4), 549-561, 2018 | 209 | 2018 |
| Prognosis of patients with diffuse large B cell lymphoma not reaching complete response or relapsing after frontline chemotherapy or immunochemotherapy J Rovira, A Valera, L Colomo, X Setoain, S Rodríguez, A Martínez-Trillos, ... Annals of hematology 94, 803-812, 2015 | 98 | 2015 |
| Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group S Alonso‐Álvarez, L Magnano, M Alcoceba, M Andrade‐Campos, ... British journal of haematology 178 (5), 699-708, 2017 | 76 | 2017 |
| Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era A Rivas‐Delgado, L Magnano, M Moreno‐Velázquez, O Garcia, F Nadeu, ... British journal of haematology 184 (5), 753-759, 2019 | 72 | 2019 |
| MYD88 L265P Mutations, But No Other Variants, Identify a Subpopulation of DLBCL Patients of Activated B-cell Origin, Extranodal Involvement, and Poor Outcome J Rovira, K Karube, A Valera, D Colomer, A Enjuanes, L Colomo, ... Clinical Cancer Research 22 (11), 2755-2764, 2016 | 72 | 2016 |
| Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression C Fernandez de Larrea, I Isola, A Pereira, MT Cibeira, L Magnano, ... Leukemia 32 (6), 1427-1434, 2018 | 63 | 2018 |
| A serum microRNA signature associated with complete remission and progression after autologous stem-cell transplantation in patients with multiple myeloma A Navarro, T Díaz, N Tovar, F Pedrosa, R Tejero, MT Cibeira, L Magnano, ... Oncotarget 6 (3), 1874, 2015 | 54 | 2015 |
| Mutational landscape and tumor burden assessed by cell-free DNA in diffuse large B-cell lymphoma in a population-based study A Rivas-Delgado, F Nadeu, A Enjuanes, S Casanueva-Eliceiry, P Mozas, ... Clinical Cancer Research 27 (2), 513-521, 2021 | 53 | 2021 |
| Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia N Giménez, A Martínez-Trillos, A Montraveta, M Lopez-Guerra, L Rosich, ... Haematologica 104 (3), 576, 2019 | 53 | 2019 |
| High serum levels of soluble interleukin-2 receptor (sIL2-R), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) are associated with adverse clinical features and … I Dlouhy, X Filella, J Rovira, L Magnano, A Rivas-Delgado, T Baumann, ... Leukemia research 59, 20-25, 2017 | 51 | 2017 |
| The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma JG Valero, A Matas-Céspedes, F Arenas, V Rodriguez, J Carreras, ... Leukemia 35 (9), 2635-2649, 2021 | 40 | 2021 |
| Autologous stem cell transplantation for follicular lymphoma: favorable long-term survival irrespective of pretransplantation rituximab exposure A Jiménez-Ubieto, C Grande, D Caballero, L Yáñez, S Novelli, ... Biology of Blood and Marrow Transplantation 23 (10), 1631-1640, 2017 | 40 | 2017 |
| Rituximab, plasma exchange and intravenous immunoglobulins as a new treatment strategy for severe HLA alloimmune platelet refractoriness J Cid, L Magnano, M Acosta, C Alba, J Esteve, M Lozano Platelets 26 (2), 190-194, 2015 | 39 | 2015 |
| Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population L Magnano, S Alonso‐Alvarez, M Alcoceba, A Rivas‐Delgado, ... British Journal of Haematology 185 (3), 480-491, 2019 | 36 | 2019 |
| Results of ARI-0001 CART19 cells in patients with chronic lymphocytic leukemia and Richter’s transformation V Ortiz-Maldonado, G Frigola, M Español-Rego, O Balagué, ... Frontiers in Oncology 12, 828471, 2022 | 29 | 2022 |
| PI3Kδ inhibition reshapes follicular lymphoma–immune microenvironment cross talk and unleashes the activity of venetoclax N Serrat, M Guerrero-Hernández, A Matas-Céspedes, A Yahiaoui, ... Blood advances 4 (17), 4217-4231, 2020 | 28 | 2020 |
| Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience P Mozas, F Nadeu, A Rivas-Delgado, A Rivero, M Garrote, O Balagué, ... Blood cancer journal 10 (3), 31, 2020 | 26 | 2020 |
| Clinicobiological features and prognostic impact of diffuse large B-cell lymphoma component in the outcome of patients with previously untreated follicular lymphoma L Magnano, O Balagué, I Dlouhy, J Rovira, K Karube, M Pinyol, ... Annals of Oncology 28 (11), 2799-2805, 2017 | 26 | 2017 |
| Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation G Gutiérrez-García, M Rovira, L Magnano, L Rosiñol, A Bataller, ... Bone Marrow Transplantation 53 (12), 1541-1547, 2018 | 23 | 2018 |
| Bone marrow plasma cell infiltration in light chain amyloidosis: impact on organ involvement and outcome N Tovar, LG Rodríguez-Lobato, MT Cibeira, L Magnano, I Isola, L Rosiñol, ... Amyloid 25 (2), 79-85, 2018 | 23 | 2018 |
